Stefania Peruzzo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Stefania Peruzzo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Fiammetta Monacelli
Ospedale Policlinico San Martino
3 shared publications - Silvia Ottaviani
University of Genoa
3 shared publications Alessio Nencioni
University of Genoa
2 shared publications- Luca Tagliafico
Geriatrics Clinic, Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, 16132 Genoa, Italy
2 shared publications - Alessio Nencioni
Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy
1 shared publication Elena Longo
Section of Geriatrics, Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, Italy
1 shared publication
Latest Publications
- 21 April 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 111 (4) , 1505-1509
Frailty in early Alzheimer's disease: Complementary clinical value and prognostic significance in biomarker-defined mild cognitive impairment due to Alzheimer's disease
Frailty, reflecting diminished physiological reserve, may influence how Alzheimer's disease (AD) pathology manifests. This study evaluated the prognostic relevance of frailty in mild cognitive impairment due to AD (MCI-AD). 50 patients underwent frailty assessment using the Clinical Frailty Scale (CFS), with multimorbidity, polypharmacy, and cognition (Mini-Mental State Examination, MMSE) recorded. Participants (median age 74 years; 76% women) exhibited low frailty (median CFS 3). Higher CFS scores correlated with lower baseline MMSE and faster annual decline. In adjusted analyses, CFS independently predicted both poorer cognition and steeper decline, whereas CSF P-tau did not. Frailty thus provides complementary prognostic information to biomarkers in the early stages of AD.
- 21 April 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 111 (4) , 1505-1509
Frailty in early Alzheimer's disease: Complementary clinical value and prognostic significance in biomarker-defined mild cognitive impairment due to Alzheimer's disease
Frailty, reflecting diminished physiological reserve, may influence how Alzheimer's disease (AD) pathology manifests. This study evaluated the prognostic relevance of frailty in mild cognitive impairment due to AD (MCI-AD). 50 patients underwent frailty assessment using the Clinical Frailty Scale (CFS), with multimorbidity, polypharmacy, and cognition (Mini-Mental State Examination, MMSE) recorded. Participants (median age 74 years; 76% women) exhibited low frailty (median CFS 3). Higher CFS scores correlated with lower baseline MMSE and faster annual decline. In adjusted analyses, CFS independently predicted both poorer cognition and steeper decline, whereas CSF P-tau did not. Frailty thus provides complementary prognostic information to biomarkers in the early stages of AD.
- Open Access
- 27 March 2026
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 56 (4) , e70194
Exploring heart rate variability as a biomarker for frailty: A narrative review
Background: Frailty is defined as a state of increased vulnerability to stressors resulting from reduced physiological homeostasis. The need to identify biomarkers capable of offering insight into the biological underpinnings of frailty and supporting early detection, diagnosis, and prognostic evaluation has grown in recent years. Heart rate variability (HRV), defined as the temporal variability between consecutive R waves of the electrocardiogram (R‐R intervals), has emerged as a promising physiological biomarker in this context. Methods: We conducted a narrative review of studies to synthesize evidence on HRV and frailty, examining analytical domains of HRV and situating findings within the current biomarker framework. Relevant literature was assessed across time‐domain, frequency‐domain, geometric and non‐linear measures of HRV, together with reported associations involving clinical, functional and cognitive outcomes. Results: Within the landscape of frailty biomarkers, HRV provides a non‐invasive index of autonomic nervous system function. Reduced HRV has been associated with frailty status, diminished physiological reserve, adverse clinical outcomes, and cognitive decline, with particularly notable findings when assessed during physiological challenges rather than at rest. It should be noted, however, that the literature is heterogeneous and methodologically inconsistent, especially regarding recording duration and the specific HRV parameters analysed. Conclusions: HRV is a highly promising physiological biomarker in the context of frailty, but further research is needed to clarify several aspects of its role. Its potential integration with other biomarkers may help confirm its validity and could contribute to identifying biomarker clusters relevant to personalized approaches.
- 27 March 2026
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 56 (4) , e70194
Open AccessExploring heart rate variability as a biomarker for frailty: A narrative review
Background: Frailty is defined as a state of increased vulnerability to stressors resulting from reduced physiological homeostasis. The need to identify biomarkers capable of offering insight into the biological underpinnings of frailty and supporting early detection, diagnosis, and prognostic evaluation has grown in recent years. Heart rate variability (HRV), defined as the temporal variability between consecutive R waves of the electrocardiogram (R‐R intervals), has emerged as a promising physiological biomarker in this context. Methods: We conducted a narrative review of studies to synthesize evidence on HRV and frailty, examining analytical domains of HRV and situating findings within the current biomarker framework. Relevant literature was assessed across time‐domain, frequency‐domain, geometric and non‐linear measures of HRV, together with reported associations involving clinical, functional and cognitive outcomes. Results: Within the landscape of frailty biomarkers, HRV provides a non‐invasive index of autonomic nervous system function. Reduced HRV has been associated with frailty status, diminished physiological reserve, adverse clinical outcomes, and cognitive decline, with particularly notable findings when assessed during physiological challenges rather than at rest. It should be noted, however, that the literature is heterogeneous and methodologically inconsistent, especially regarding recording duration and the specific HRV parameters analysed. Conclusions: HRV is a highly promising physiological biomarker in the context of frailty, but further research is needed to clarify several aspects of its role. Its potential integration with other biomarkers may help confirm its validity and could contribute to identifying biomarker clusters relevant to personalized approaches.
- Open Access
- 14 November 2025
- Published by Springer Nature in European Geriatric Medicine
- Vol. 17 (2) , 665-672
Impact of pressure ulcers and frailty on long-term mortality: a prospective cohort study of hospitalized older adults
Purpose: This study investigates the impact of pressure ulcers (PU) on long-term survival in hospitalized older adults, to understand how frailty and PU interact to influence mortality and to explore their independent prognostic accuracy. Methods: Between February 21, 2022, and July 1, 2022, 324 patients (198 female, 126 male; mean age: 86), admitted to the Geriatric Unit and Transitional Care of San Bartolomeo Hospital, Sarzana, Italy, were enrolled. A comprehensive geriatric assessment (CGA) was performed by geriatricians, including the assessment of frailty using the Clinical Frailty Scale (CFS), and PU assessment, carried out by a trained nurse. Long-term mortality (median duration: 18 months) was collected through the regional electronic health data system with an 18-month follow-up period. Results: Older adults with PU had advanced frailty, higher nutritional risk, increased disability, and higher polypharmacy. Multivariate analysis showed that both frailty (CFS: HR 1.535, 95% CI 1.314–1.793, p < 0.001) and PU (HR 1.500, 95% CI 1.059–2.126, p = 0.020) were significant predictors of long-term mortality. Namely, each increment in CFS score was associated with a 53% increased risk in PU carriers. No significant interaction between CFS and PU on survival outcomes was found. Conclusion: The study underscored the independent prognostic significance of both PU and frailty in predicting long-term mortality in hospitalized older adults. A multidimensional approach considering both frailty and PU is crucial for accurate prognostication and improving care strategies for older patients.
- 14 November 2025
- Published by Springer Nature in European Geriatric Medicine
- Vol. 17 (2) , 665-672
Open AccessImpact of pressure ulcers and frailty on long-term mortality: a prospective cohort study of hospitalized older adults
Purpose: This study investigates the impact of pressure ulcers (PU) on long-term survival in hospitalized older adults, to understand how frailty and PU interact to influence mortality and to explore their independent prognostic accuracy. Methods: Between February 21, 2022, and July 1, 2022, 324 patients (198 female, 126 male; mean age: 86), admitted to the Geriatric Unit and Transitional Care of San Bartolomeo Hospital, Sarzana, Italy, were enrolled. A comprehensive geriatric assessment (CGA) was performed by geriatricians, including the assessment of frailty using the Clinical Frailty Scale (CFS), and PU assessment, carried out by a trained nurse. Long-term mortality (median duration: 18 months) was collected through the regional electronic health data system with an 18-month follow-up period. Results: Older adults with PU had advanced frailty, higher nutritional risk, increased disability, and higher polypharmacy. Multivariate analysis showed that both frailty (CFS: HR 1.535, 95% CI 1.314–1.793, p < 0.001) and PU (HR 1.500, 95% CI 1.059–2.126, p = 0.020) were significant predictors of long-term mortality. Namely, each increment in CFS score was associated with a 53% increased risk in PU carriers. No significant interaction between CFS and PU on survival outcomes was found. Conclusion: The study underscored the independent prognostic significance of both PU and frailty in predicting long-term mortality in hospitalized older adults. A multidimensional approach considering both frailty and PU is crucial for accurate prognostication and improving care strategies for older patients.